mTOR and its signal pathway components are closely related to recurrence and metastasis of gastric cancer, so the targeted drugs against mTOR combined with chemotherapy agents show great application potentials for avoiding the recurrence and metastasis of gastric cancer. In this paper, the authors present the recent progress in the mechanisms underlying mTOR signaling pathway-mediated recurrence and metastasis of gastric cancer.